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ABSTRACT: Given that basal levels of reactive oxygen species (ROS) are higher in
cancer cells, there is a growing school of thought that endorses pro-oxidants as
potential chemotherapeutic agents. Intriguingly, cerium oxide (CeO2) nanoparticles
can manifest either anti- or pro-oxidant activity as a function of differential pH of
various subcellular localizations. In an acidic pH environment, for example, in
extracellular milieu of cancer cells, CeO2 would function as a pro-oxidant. Based on
this concept, the present study is designed to investigate the pro-oxidant activities of
CeO2 in human colorectal carcinoma cell line (HCT 116). For comparison, we have
also studied the effect of ceria nanoparticles on human embryonic kidney (HEK 293)
cells. Dose-dependent viability of cancerous as well as normal cells has been assessed
by treating them independently with CeO2 nanoparticles of different concentrations
(5−100 μg/mL) in the culture media. The half maximal inhibitory concentration
(IC50) of nanoceria for HCT 116 is found to be 50.48 μg/mL while that for the HEK
293 cell line is 92.03 μg/mL. To understand the intricate molecular mechanisms of CeO2-induced cellular apoptosis, a series of
experiments have been conducted. The apoptosis-inducing ability of nanoceria has been investigated by Annexin V-FITC staining,
caspase 3/9 analysis, cytochrome c release, intracellular ROS analysis, and mitochondrial membrane potential analysis using flow
cytometry. Experimental data suggest that CeO2 treatment causes DNA fragmentation through enhanced generation of ROS, which
ultimately leads to cellular apoptosis through the p53-dependent mitochondrial signaling pathway.
■ INTRODUCTION
Free-radical-induced oxidative injury is considered to be the
fundamental mechanism underlying several human diseases
such as neurodegenerative diseases, cancer, stroke, and
numerous other ailments. Owing to its potential to prevent,
delay, or ameliorate the physiological disorders caused or
aggravated by ROS, antioxidant therapy is of enormous clinical
interest.1 Although a gamut of preclinical in vitro and animal
data suggest inverse associations between antioxidants and the
risk of various cancers, clinical trial results are not convincing
enough in many cases, especially in the setting of chronic
preventative therapy.2,3 Hence, the need of the hour is to focus
on designing more disease-specific, target-directed, and highly
bioavailable therapeutics, along with the choice of optimal
treatment times and durations.
In view of the aberrant redox status of cancer cells, the
current treatment regimen relies on pro-oxidant therapies,
which is efficacious in selectively inducing cancer cell death via
oxidative stress, while sparing the “normal cells.” Cancer cells,
because of a loss in proper redox control, exhibit an elevated
level of ROS production, as compared to healthy cells.4 Pro-
oxidant chemotherapeutic agents induce additional oxidative
stress in cancer cells, thereby driving them into apoptotic cell
death. A similar level of oxidative stress induced by the pro-
oxidants, when administered in a calibrated dose, would not
cross the apoptotic threshold in normal cells.5 Therefore,
controlled enhancement of intracellular ROS production,
below cytotoxic threshold, by the use of pro-oxidative
substances is instrumental in cancer treatment.
With the emergence of nanomedicine, nanoparticles are
being extensively investigated as potential cargos for delivery of
therapeutic drugs to specific cellular targets or organs, for
example, to mitochondria6 or to the brain.7 Nanoparticles, with
inherent pharmacological attributes, are gaining special
attention because of their tremendous potential in anticancer
therapy. By virtue of their redox-modulatory and enzyme-like
activities, cerium oxide (CeO2) nanoparticles are envisaged as
promising candidates in nanomedicine. Ceria nanoparticles
have been shown to act as catalysts that mimic a series of redox
enzymes, including superoxide dismutase, catalase, peroxidase,
phosphotriesterase, phosphatase, and oxidase, which can
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scavenge reactive oxygen species (ROS).8−14 The enzyme-
mimicking activities of CeO2, for free-radical scavenging, have
been ascribed to the auto-regenerative cycle of Ce3+/Ce4+ and
oxygen vacancies on the surface of ceria.15 Recent studies
demonstrating the neuroprotective and cardioprotective roles
of CeO2 nanoparticles have been correlated with its
antioxidative and redox-modulatory activities.16,17 On the
other hand, nanoceria have been found to produce significant
oxidative stress in human bronchoalveolar carcinoma and18
human hepatocellular carcinoma.19 In the case of lung
adenocarcinoma (A549) cells, CeO2 increases the production
of ROS which leads to a decrease in the antioxidant level of
cells and apoptotic cell death.20 The elevated levels of ROS
also cause damage to DNA and halts cell cycle progression.
Studies have also shown that co-treatment with ceria
nanoparticles and radiation therapy caused significant
activation of c-Jun terminal kinase, a key driver of radiation
therapy-induced apoptosis, in human pancreatic cancer cells.21
Intriguingly, cytotoxicity and genotoxocity of CeO2 is
preferential to cancer cells, whereas inverse effects are observed
for healthy cells. For example, more than two-fold increase in
radiation-induced ROS production was observed in human
pancreatic cancer cells (L3.6pl) treated with 10 μM ceria
nanoparticles for 24 h, while a similar treatment led to a
constant decrease (>50%) in radiation-induced ROS produc-
tion for normal pancreatic cells (hTERT-HPNE).22 Selective
cytoprotection provided by nanoceria to normal cells, but not
to cancer cells, during oxidative stress may be explained by the
pH-dependent oxidation state of the material. It is observed
that CeO2 exhibits optimal antioxidant properties at
physiological pH, whereas it behaves as an oxidase at acidic
pH.14 Noticeably, in solid tumors, the preferential dependence
of cancer cells on glycolysis (Warburg effect) leads to a
lowering of tumor cell pH.23 In acidic environments, CeO2
favors the scavenging of superoxide radicals over the hydrogen
peroxide, resulting in accumulation of the latter whereas in
neutral pH (healthy cells), ceria scavenges both.19 Nonethe-
less, the multimechanistic nature of the ceria-mediated
modulation of intracellular ROS ratifies the rationale for its
extensive exploration in cancer therapy.
The present study is aimed to understand the molecular
mechanism underlying the toxicity of CeO2 nanoparticles on
human colorectal carcinoma cell line (HCT 116). The cancer
cells have been treated with different concentrations of pristine
nanoceria, synthesized using a chemical precipitation method.
Owing to the nontrivial influence of surface defects and oxygen
vacancies on the ROS modulating properties of CeO2, we
refrained from capping the nanoparticle surface with
surfactants or organic molecules, which can potentially inhibit
a set of pro-oxidant biological effects. As indicators of
apoptosis, DNA fragmentation, activation of caspase-3 and
caspase-9, as well as Bcl-2 expression has been explored. To
understand the molecular mechanism of ceria-induced
oxidative stress, a plethora of in vitro toxicity indices have
been conducted, focusing on the involvement of the death-
responsive cellular mechanism.
■ RESULTS AND DISCUSSION
Characterization of CeO2 Nanoparticles.Morphological
characterization of pristine CeO2 nanoparticles was performed
by transmission electron microscopy (TEM). Figure 1A
presents clusters of pristine CeO2 nanoparticles, the majority
of which are in the range of 30−40 nm. The tendency of
pristine CeO2 to form clusters on the TEM grid could be
Figure 1. (A) TEM image of the CeO2 nanoparticles; (B) HRTEM image of the nanoparticles with pronounced lattice fringes, inset:
corresponding FFT pattern; and (C) XRD spectra for CeO2 nanoparticles. Manifestation of the {111} plane is apparent from the relative intensities
of the XRD peaks; (D) FTIR spectra of pristine CeO2 nanoparticles.
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ascribed to a low zeta potential (−4.9 mV) of the pristine
nanoparticles in aqueous medium. The intrinsic presence of
hydroxyl ions on the particle surface would facilitate the
formation of hydrogen bond between particles, resulting in soft
aggregation. High-resolution TEM (HRTEM) (Figure 1B)
reveals the lattice fringes with the d-spacing of 0.32 nm, which
could be indexed to the (111) plane of ceria. The value of
interplanar spacing is in agreement with the fast Fourier
transform (FFT) calculations (inset of Figure 1B). The X-ray
diffraction (XRD) pattern of pristine ceria nanoparticles is
shown in Figure 1C in the 2θ range of 25−80°. All of the
discernible peaks could be indexed to a pure cubic (fluorite)
structure of CeO2 (space group: Fm3̅m) with a lattice constant
a = 5.411 Å, which is in agreement with the JCPDS file for
CeO2 (JCPDS 34-394). Noticeably, in the XRD spectra the
highest intensity diffraction peak is located at 2θ = 28.660°,
which is from the (111) lattice plane of face-centered cubic
form of CeO2. The abovementioned observation is corrobo-
rated with the interplanar spacing of the (111) plane, as
calculated from the HRTEM image. Figure 1D divulges the
chemical fingerprints of pristine ceria. In the Fourier-transform
infrared (FTIR) spectrum of pristine CeO2, the broad intense
band at around 3425 cm−1 corresponds to the O−H stretching
vibration of adsorbed water and hydroxyl groups on the
nanoparticle surface (Ce−H), whereas the peak at 1628 cm−1
arises because of the scissor bending of internally bonded water
molecules.24 The peak at 1384 cm−1 represents the N−O
stretch because of the residual presence of nitrate.25 The
intense absorption band in the low wave-number region (600−
500 cm−1), as well as the small peak at around 850 cm−1, are
the characteristics of Ce−O vibrations.26
Viability of HCT 116 Colon Cancer Cell Line. Exposure
to CeO2 at different concentrations (5, 10, 20, 40, 60, 80, and
100 μg/mL) led to cell death with a significantly lower IC50 of
50.48 μg/mL, as compared to the relatively toxic anticancer
drug. At a dose of 28.12 and 72.86 μg/mL, 30 and 70% of cell
deaths were observed, respectively (Figure 2). Thus, three
concentrations (30, 50, and 70 μg/mL) on the basis of IC30,
IC50, and IC70 were chosen for the entire study to evaluate the
molecular mechanism of action. For comparison with normal
(noncancerous) cell line, we have studied the cytotoxicity of
CeO2 in the human embryonic kidney (HEK 293) cell line by
an MTT assay after 24 h of treatment (Figure S1 in the
Supporting Information). The results suggest that up to 37 μg/
mL there was almost no cytotoxicity. The calculated value of
IC50 for HEK 293 cell line was 92.03 μg/mL. In fact, the
inhibitory concentrations IC30, IC50, and IC70 are substantially
less for HCT 116, as compared to those for HEK 293 cell lines,
suggesting that cerium oxide is a potent anticancer agent.
Molecular Mechanisms of CeO2-Induced Cellular
Apoptosis. Numerous scientific reports demonstrated that
nanoparticle-assisted anticancer activity was guided through
the generation of intercellular ROS (iROS). Thus, to evaluate
the correlation between anticancer activity and intercellular
ROS generation upon CeO2 treatment, flow cytometric
assessment was carried out using ROS-sensitive indicator
H2DCF-DA (2′,7′-dichlorofluorescein diacetate). A dose-
dependent (30, 50, and 70 μg/mL) augmentation of DCF
fluorescence (DCF+ population) in terms of ROS upon CeO2
treatment was observed with respect to the control cells,
suggesting that CeO2-generated ROS could be a potent
inducer of cellular death (Figure 3A). CeO2-induced cell death
was further confirmed by the assessment of apoptosis and
necrosis using Annexin V-FITC and DAPI staining. External-
ization of phosphatidylserine from lipid bilayer upon cell death
is the hallmark indicator of apoptosis as changes in the
membrane asymmetry can contribute numerous cellular
functions associated with apoptosis. Annexin V binds to
phosphatidylserine when it is present on the outer leaflet of the
plasma membrane. Flow cytometric analysis revealed that %
cell population in early (Annexin V-FITC+ population) and
late apoptosis (Annexin V-FITC+/DAPI+ population) was
increased markedly with the treatment of CeO2 in a dose-
dependent (30, 50, and 70 μg/mL) manner (Figure 3B). A
unique feature of the early stages of apoptosis is the disruption
of active mitochondrial function that includes changes in the
membrane potential and alterations to the oxidation−
reduction potential of the mitochondria.27 Thus, to validate
the CeO2-induced apoptosis was associated with the
modification of mitochondrial membrane potential (MMP);
JC-1 was used to detect the changes in mitochondrial health in
terms of potential difference. JC-1, a membrane-permeant dye,
exhibits potential-dependent accumulation in mitochondria
which is indicated by a decrease in the red/green fluorescence
intensity.28 Ceria treatment markedly increased the JC-1 green
fluorescence intensity in a dose-dependent manner with
respect to the control cells (Figure 3C). The maximum
change in JC-1 red/green fluorescence intensity ratio was
found when cells were treated with 70 μg/mL of CeO2 (Figure
3C). The data suggested that CeO2 treatment could alter the
MMP following the induction of apoptotic machinery.
Apoptosis is an intricate mechanism for programmed cell
death and is associated with the modulation of plethora of
cellular signaling proteins. Earlier reports demonstrated that
two types of proteins, especially antiapoptotic Bcl2 family of
proteins regulate apoptosis by controlling mitochondrial
permeability that resides in the outer mitochondrial wall
inhibiting cytochrome c release.29 The other proteins, namely
pro-apoptotic Bax and Bak which lie in the cytosol but
translocate to mitochondria following the stress signaling,
where they promote the release of cytochrome c from the
mitochondria.30,31 Upon liberation from mitochondria, cyto-
chrome c binds to Apaf-1 and forms an activation complex with
caspase-9 which further recruits and cleaves caspase-9 and
caspase-3.32 The sequential activation of caspases allows
running execution-phase of cell apoptosis through the cleavage
of other regulatory proteins.33,34
To justify whether the mechanism of apoptosis upon CeO2
treatment was mitochondrial dependent or not, flow
cytometric evaluation of protein expression was conducted.
Figure 2. Nanoceria dose-dependent viability of HCT 116 colorectal
carcinoma cell line (after 24 h).
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An enhanced relative fluorescence intensity of Bax-FITC
(Figure 4A), Bak-FITC (Figure 4C), and cytochrome c-FITC
(Figure 4D) were found when the cells were treated with CeO2
in a dose-dependent manner. On the other hand, the
antiapoptotic protein Bcl2 was markedly decreased as well
(Figure 4B), indicating the imbalance between pro- and
antiapoptotic protein expressions that could facilitate the
apoptotic burden.
The results also demonstrated that the apoptotic load was
executed finally in the activation of caspase as CeO2 treatment
markedly enhanced the caspase-3 and caspase-9 activity in
graded doses (30, 50, and 70 μg/mL), while it was gradually
decreased with the co-treatment of caspase inhibitor, Z-VAD-
FMK (Figure 4E). A growing body of evidence suggested that
mitochondrial-dependent apoptosis is typically initiated by
DNA damage which further modulates cellular redox status
associated with the cell death mechanism.35,36 Histone H2AX
phosphorylated on serine 139 (γ-H2AX), one of the hallmarks
of DNA damage and DNA double-strand breaks (DSB), is
modulated through iROS. Thus, to assess the role of CeO2 in
the induction of DNA damage, immunofluorescence study was
carried out to detect the phosphorylation of γ-H2AX
underlying the foci formation in the nucleus. A significant
number of γ-H2AX foci were located when the cells were
treated with 50 μg/mL of CeO2 (IC50) which was further
increased in 70 μg/mL of treatment (IC70) (Figure 5). These
data confirmed that CeO2 could involve the apoptosis
mechanism through the phosphorylation of γ-H2AX. The
primary DSB indicator, γ-H2AX, further activates one of the
major redox-assisted transcription factor, p53, that is involved
in the regulation of DNA repair to allow the lesions to be
repaired or lead to programmed cell death. In cytoplasm, the
activity of p53 is masked through the inhibitory action of
Mdm2 which act as a negative regulator and functions as a
ubiquitin ligase.37 Upon DNA damage, phosphorylation of p53
disrupts the Mdm2 binding, and the inhibitory masking is
withdrawn following the nuclear translocation.38 In particular,
p53 enhances p21 transcription in the nucleus, which in turn
inhibits cyclin-dependent kinase activity followed by the
prevention of pRb from derepressing E2F1 which suppress
the progression from G1 to S phase.39 The current study
revealed that the expression of Mdm2 was suppressed when
the cells were treated with CeO2 in a dose-dependent manner
as evident from a gradual decrease in AF488 relative
fluorescence intensity (Figure 5), supporting the fact that
CeO2 triggered the disruption of Mdm2 from p53 upon the
phosphorylation of γ-H2AX.40,41 On one hand, a gradual
increase in the phosphorylation of p53 was also evidently
correlating the hypothesis underlying the role CeO2-induced
disruption of Mdm2 which further induced the nuclear
translocation of p53 as CeO2 treatment enhanced the p-p53-
FITC fluorescence intensity in the nucleus (Figure 6).
Figure 3. (A) ROS level of 30, 50, and 70 μg/mL CeO2-treated HCT 116 cells after 24 h; (B) flow cytometric analysis of Annexin V-FITC/DAPI-
binding levels of 30, 50, and 70 μg/mL CeO2-treated HCT 116 cells after 24 h; (C) dose-dependent change in MMP with 30, 50, and 70 μg/mL
CeO2-treated HCT 116 cells after 24 h.
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Furthermore, it is apparent from Figure 6 that phosphorylation
of p53 also elicited the p21 activation as CeO2 treatment
markedly increased the p21 expression as well as the
colocalization with p53, indicating that CeO2-induced
phosphorylation of p53 activated two pathways, DNA repair
along with apoptosis.42 The results also showed that CeO2
treatment markedly increased nuclear fragmentation as evident
from altered comet indices (Figure 7). The ROS-induced
DNA damage was also confirmed by the DNA fragmentation
assay (Figure S2 in the Supporting Information). The data
suggested that DNA fragmentation was increased in a CeO2
dose-dependent manner. Biochemical events leading to the
apoptotic changes include blebbing, cell shrinkage, nuclear
fragmentation, chromatin condensation, and chromosomal
DNA fragmentation which confirmed the observed data that
CeO2 treatment may modulate apoptosis through the p53-
dependent mitochondrial-assisted pathway (Figure 8).
■ CONCLUSIONS
The present study has shown that CeO2 nanoparticles inhibit
the proliferation of colon cancer cells (HCT 116) in a dose-
dependent manner and can induce apoptosis through the
generation of intercellular ROS. Interestingly, for normal cells
such as HEK 293 cell line, a significantly reduced cytotoxicity
is observed. Furthermore, CeO2-induced apoptosis could be
correlated with alteration of MMP, caspase activation, and
chromosomal DNA fragmentation. Nanoceria has been found
as a bona fide anticancer agent that acts in a p53-dependent
manner. In the future, pristine CeO2 nanoparticles, or those
conjugated with the specified antibody or anticancer drugs,
may be applied for colon cancer therapy, without the adverse
effects rendered by the conventional chemotherapeutic drugs.
■ MATERIALS AND METHODS
Materials. Cerium(III) nitrate hexahydrate [Ce(NO3)3·
6H2O, 99%], ethylene glycol (EG, 99.8%), and (3-
aminopropyl)triethoxysilane (≥98% pure) were procured
from Sigma-Aldrich (Germany) and were used without further
purification. The solutions were prepared using deionized (DI)
water from Milli-Q Direct Water Purification System (Merck
Millipore, Billerica, MA, USA).
HCT 116 and HEK 293 cell lines were obtained from
NCCS Pune, India. Dulbecco’s modified Eagle medium
(DMEM), fetal bovine serum (FBS), penicillin streptomycin
neomycin (PSN) antibiotic, trypsin, and ethylenediaminetetra-
acetic acid (EDTA) were obtained from Gibco BRL (Grand
Island, NY, USA). Tissue culture plastic wares were purchased
from NUNC (Roskilde, Denmark). 3-(4,5-Dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT), 4′,6-diamidino-
2-phenylindole (DAPI), and ethidium bromide (EtBr) were
purchased from SRL (India). Antibodies and all other
chemicals used were procured from Sigma-Aldrich (St. Louis,
MO, USA).
Synthesis of Cerium Oxide Nanoparticles. Cerium
oxide nanoparticles were synthesized using EG-assisted
ammonia-induced precipitation method. Briefly, 7.8 mL EG
was added to 92.2 mL of DI water in a 250 mL of two-neck
round bottom flask at 50 °C in a silicone bath reflux condenser
system and kept under constant stirring at 350 rpm.
Subsequently, 5.16 g of cerium nitrate was added into the
EG/water solution at a molar ratio of 10:1. After complete
Figure 4. (A) Level of Bax; (B) Bcl2; (C) Bak; (D) cytochrome c positive cells; (E) dose-dependent level of active caspase 3 and active caspase 9
after treatment with CeO2 nanoparticles with and without Z-VAD-FMK.
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Figure 5. Localization of Mdm2 and generation of γ-H2AX foci after treatment of CeO2 at 30, 50, and 70 μg/mL of HCT 116 by confocal
microscopy.
Figure 6. Localization of p53 and p21 after treatment of CeO2 at 30, 50, and 70 μg/mL of HCT 116 by confocal microscopy.
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dissolution of cerium nitrate, 5 mL of aqueous ammonia was
added to the solution, and the pH was adjusted to 9.6. The
solution was kept under constant magnetic stirring at 750 rpm
until the color of the solution turned yellowish, which
indicated formation of cerium oxide. Subsequently, the
solution was subjected to vacuum filtration using Whatman
(Ø = 110 mm and grade 589/3) filter paper, washed
alternately with ethanol and DI water, and dried overnight
under vacuum. Finally, the as-synthesized materials were
calcined at 400 °C for 2 h to obtain phase-pure CeO2
nanoparticles.
Characterization of the Nanoparticles. The morphol-
ogy of the prepared ceria nanoparticles was characterized by
TEM using a JEOL JEM 2100 high resolution transmission
electron microscope. Nitrogen adsorption and desorption
isotherms at 77 K were measured using a NOVA 4000E
Surface Area Analyzer system (Quantachrome Instruments,
FL, USA). The samples were pretreated at 300 °C for 2 h
under vacuum. Data analysis was performed using NOVAWin
software (version 10.01). Zeta potential (ζ), the overall surface
charge of the nanoparticles in solution (∼1 mg/mL in DI
water at pH 7.4) was assessed by an electrophoretic light
scattering Zetasizer Nano ZS zeta potential analyzer (Malvern
Instruments Ltd, Malvern, UK). FTIR spectroscopy using an
IRPrestige-21 spectrophotometer (Shimadzu Corporation,
Tokyo, Japan) was performed to substantiate the presence of
reactive amino silane moieties on the modified metal-oxide
surface. An X-ray diffractometer (Rigaku Ultima III, Tokyo,
Japan) determined the phase analysis of the nanoparticles,
carried out using Cu Kα radiation (λ = 0.15418 nm) in a
continuous scan mode from 20 to 80° at a scan speed of 1°/
min.
Cell Culture. HCT 116 and HEK 293 cell lines were
independently cultured in DMEM with 10% FBS and 1% PSN
antibiotic mixture at 37 °C in a humidified atmosphere under
5% CO2. After 75−80% confluence, cells were harvested with
0.52 mM EDTA and 0.25% trypsin in phosphate buffered
saline (PBS) and seeded at required density to allow them to
re-equilibrate for a day before starting the experiment.
Cell Viability Assays. For defining the cell viability, an
MTT assay was performed. For the initial screening, HCT 116
or HEK 293 cells were seeded (4 × 103 cells per well) in 96
well plate and maintained at 37 °C in a humidified 5% CO2
atmosphere. Cell viability was assessed by treatment of CeO2
at different concentrations (5, 10, 20, 40, 60, 80, and 100 μg/
mL). Nanoparticle-treated plates were kept in an incubator for
24 h, following which the cells were washed with PBS.
Figure 7. (A) Comet assay results after incubation of HCT 116 cells with treatment of CeO2 at 30, 50, and 70 μg/mL; (B) head diameter, (C) %
DNA in tail, (D) tail length; and (E) olive tail moment.
Figure 8. Plausible mechanism of CeO2-induced apoptosis of human
colon cancer cells (HCT 116) by ROS-generated mitochondrial-
mediated pathway.
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Subsequently, MTT solution (4 mg/mL in PBS) was added in
each well and kept in the incubator for 4 h. Absorbance of the
solubilized intracellular formazan was calculated at 595 nm
using an ELISA reader (EMax, Molecular Devices LLC, San
Jose, CA, USA). In all cases, the nanoparticle suspensions were
sonicated before being added to the cell culture to obtain
homogenized mixtures. The cell culture assays were repeated
in triplicate at the desired concentrations.
Quantification of Apoptosis Using Annexin V-FITC.
Apoptosis was assayed through the use of an Annexin V-FITC
apoptosis detection kit (Calbiochem, CA, USA). After treating
with CeO2 nanoparticles (30, 50, and 70 μg/mL as per IC30,
IC50, and IC70, respectively) for 24 h, the cells were washed
and stained with Annexin V-FITC, which is in accordance with
the manufacturer’s instructions. The percentages of live,
apoptotic, and necrotic cells were evaluated by flow cytometry
(BD LSRFortessa, San Jose, CA, USA).
Measurement of MMP. For measuring MMP, cells were
treated with CeO2 (30, 50, and 70 μg/mL as per IC30, IC50,
and IC70, respectively) for 24 h and then incubated with JC-1
(5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolylcarbo-
cyanine iodide, Sigma) at 37 °C, 5% CO2 for 30 min. After
incubation, centrifugation was carried out at 400g for 5 min at
room temperature, and the supernatant was removed. Then,
the cell pellets were suspended in 500 μL PBS. Data from 106
cells were analyzed in a BD LSRFortessa (San Jose, CA, USA)
cell analyzer for each sample. For healthy cells, having high
MMP, the reagent gives fluorescence in the FITC channel for
green monomers, as compared to apoptotic cells, indicating a
significant drop in the MMP resulting in PE-Texas Red A
channel for dead aggregates.
Measurement of Intracellular ROS. Mitochondria are
the major sites of ROS production in mammalian cells, and
superoxide (O2
−) seems to be the primary ROS produced as
the result of single electron reduction of O2. ROS plays an
important role in the motivation of apoptosis in a variety of
cells. For measuring the ROS generation, cells were treated
with CeO2 (30, 50, and 70 μg/mL as per IC30, IC50, and IC70,
respectively) for 24 h and incubated with 10 μM of H2DCF-
DA at 37 °C for 25 min, and then, cells were analyzed by flow
cytometry. The increase in fluorescence because of production
of ROS was noted by a flow cytometer (BD LSRFortessa, San
Jose, CA, USA). For data of each sample, 1 × 106 cells were
analyzed.
Caspase-3 and Caspase-9 Activity Assays. HCT 116
cells were treated with CeO2 (30, 50, and 70 μg/mL as per
IC30, IC50, and IC70, respectively) for 24 h, and caspase-3 and
caspase-9 activities were quantified with the commercially
available caspase-3 and caspase-9 colorimetric assay kit
(BioVision Research Products, Mountain View, CA), respec-
tively. Caspase activities were detected at 405 nm by a
spectrophotometer on an ELISA reader.
Analysis of Protein Expression by Flow Cytometry.
After treatment with CeO2 (30, 50, and 70 μg/mL as per IC30,
IC50, and IC70, respectively) fixation of cells was carried out by
4% paraformaldehyde in PBS (pH 7.4) for 20 min at room
temperature. 0.1% Triton X-100 in PBS was used for
permeabilization with 0.1% FBS for 5 min. After washing
twice with PBS with 3% FBS, the permeabilized cells were
incubated with primary antibody on ice for 2 h and washed
with PBS. Then, the cells were incubated with FITC-
conjugated goat anti-rabbit IgG as secondary antibody for 2
h on ice and washed twice with PBS. The stained cells were
acquired and analyzed using a BD LSRFortessa flow cytometer
(San Jose, CA, USA) equipped with FlowJo software.
Confocal Microscopy. Briefly, after treatment with CeO2,
the cover slips containing HCT 116 cells were washed twice
for 10 min each in 0.01 M PBS and incubated for 1 h in
blocking solution containing 2% normal bovine serum and
0.3% Triton X-100 in PBS. After blocking, the slides were
incubated overnight at 4 °C with the proper primary antibody.
Fluorophore-conjugated secondary antibodies were diluted
1:100 in the blocking solution and incubated for 2 h. The
slides were then counterstained with DAPI for 10 min and
mounted with the ProLong Anti-fade Reagent (Molecular
Probe, Eugene, OR, USA). Staining images of the double
immunofluorescence were examined using a confocal laser-
scanning microscope (FV 10i, Olympus, Japan).
Assessment of Nuclear DNA Damage Using Single
Cell Gel Electrophoresis Assay. The oxidative DNA
damage was measured by performing the comet assay. The
CeO2-treated cells were mixed with 100 mL of 0.5% low
melting agar (LMA) at 39 °C and then spread on a fully
frosted microscopic slide precoated with 200 mL of 1% LMA.
After agarose solidification, the slide was covered with 75 mL
of 0.5% LMA and immersed in lysis solution (2.5 M NaCl, 100
mM Na-EDTA, 10 mM Tris, 1% Trion X-100 and 10%
DMSO, pH 10) for 1 h at 4 °C. The slides were employed in a
gel-electrophoresis apparatus containing 300 mM NaOH and
10 mM Na-EDTA (pH 13) for 40 min to allow DNA
unwinding and the expression of alkali-labile damage. An
electrical field was applied (300 mA, 25 V) for 20 min at 4 °C
to draw negatively charged DNA toward the anode. After
electrophoresis, the slides were washed three times for 5 min at
4 °C in a neutralizing buffer (0.4 M Tris pH 7.5) and then
stained with 75 mL EtBr solution (20 mg/mL). The slides
were photographed using a fluorescence microscope, and the
images were analyzed by CometScore software (v1.5).
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